Degarelix Powder and Solvent for Suspension for Injection.
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2012
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 12 May 2009 Additional locations (Romania, Hungary, Czech Republic) identified as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History